progress on mdg4 and mdg5: implications for the us

10
UNIVERSITY OF WASHINGTON Progress on MDG4 and MDG5: Implications for the US May 24, 2010

Category:

Education


1 download

DESCRIPTION

IHME's Dr. Murray presents information on the progress towards Millenium Development Goals 4 and 5, summarizing key findings and their implications for US global health policy.For more information visit www.healthmetricsandevaluation.org

TRANSCRIPT

Page 1: Progress on MDG4 and MDG5: implications for the US

UNIVERSITY OF WASHINGTON

Progress on MDG4 and MDG5: Implications for the US

May 24, 2010

Page 2: Progress on MDG4 and MDG5: implications for the US

2

New Evidence on Progress on MDG4 and MDG5

1) New studies in the Lancet in April 2010 on MDG5 and today on MDG4 provide a more robust basis for assessing progress on maternal mortality and under-5 deaths.

2) These studies by researchers at the Institute for Health Metrics and Evaluation and the University of Queensland have brought together much larger datasets and used improved estimation methods with proven accuracy.

3) Technical Symposium today will explore the database, methods and findings in detail and provide an opportunity to discuss alternative views on all aspects of these studies.

4) Goal is to summarize the key findings and their implications for US global health policy.

Page 3: Progress on MDG4 and MDG5: implications for the US

Global Under-5 Deaths

3

Global Maternal Deaths

Progress

Page 4: Progress on MDG4 and MDG5: implications for the US

Maternal and Under-5 Deaths are Concentrated in Four Regions

U5 Deaths 2010

Maternal Deaths 2008

Page 5: Progress on MDG4 and MDG5: implications for the US

Annual Rate of Decline in U5 1990-2010

5

Progress on Under-5 Death Rates is Highly Variable Across Countries

Page 6: Progress on MDG4 and MDG5: implications for the US

Progress on Under-5 Mortality is Accelerating in Low-Income Countries

• 13 regions have faster rates of decline in under-5 mortality from 2000 to 2010 than from 1990 to 2000.

• 34 countries in sub-Saharan Africa have faster rates of decline.

• Dramatic acceleration in declines in East Asia and Central Asia.

6

Page 7: Progress on MDG4 and MDG5: implications for the US

Annual Rate of Decline in MMR 1990 to 2008

7

Huge Range in Progress on the MMR Including Rising Rates in Some Countries

Page 8: Progress on MDG4 and MDG5: implications for the US

Progress on MDG4 and MDG5 Can be Different0

12

34

5

ann

ualiz

ed

dec

line

in 5

q0

(%)

-4 -2 0 2 4 6annualized decline in MMR (%)

Asia Pacific, High Income

Australasia

Europe, Western

Latin America, Southern

North America, High Income

Asia, Central

Europe, Central

Europe, Eastern

Asia, East

Asia, Southeast

Oceania

Asia, South

Caribbean

Latin America, Andean

Latin America, Central

Latin America, Tropical

North Africa/Middle East

Sub-Saharan Africa, Central

Sub-Saharan Africa, East

Sub-Saharan Africa, Southern

Sub-Saharan Africa, West

Annualized Percent Decline in 5q0 and MMR; 1990-2008

Equivalence Line

Page 9: Progress on MDG4 and MDG5: implications for the US

9

Likely Key Drivers of Progress

1) Expansion of levels of maternal education. Average years of schooling of mothers in sub-Saharan Africa has increased from 1.5 years in 1980 to 4.4 years in 2008

2) Rising levels of income in Asia, Middle-East and Latin America.

3) Declines in the fertility rate although slower in sub-Saharan Africa.

4) Peak impact on children and mothers of HIV was from 1995-2004, now the impact is decreasing.

5) Increasing access to bednets, vaccination, vitamin A supplementation, prenatal care and skilled birth attendance and other MCH intervention technologies.

Page 10: Progress on MDG4 and MDG5: implications for the US

10

Implications

1) Expansion of development assistance for health to nurture accelerated progress particularly in sub-Saharan Africa.

2) Prioritize policy studies to elucidate why some countries such as Malawi, Madagascar, Niger and Ethiopia have been successful for reducing child mortality and countries such as Egypt, Bolivia, Ecuador, or Rwanda for maternal mortality.

3) Intensify investments in tracking maternal mortality and child mortality using methods that allow more timely assessment of trends.

4) Build synergies between investments in HIV programs and maternal and child health.

5) Judiciously balance investments in countries demonstrating accelerated progress and those most in need.